FIRST SCHEDULE
Regulations 2(1) and 6(3) and (4)
Vaccination and approved vaccines
First column
Second column
Third column
Fourth column
Approved vaccine
Vaccination
Start
End
1.Tozinameran (Pfizer-BioNTech COVID‑19 vaccine or Comirnaty COVID-19 vaccine)
(1)Two doses, administered at least 17 days apart.
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 17 days after the firstmentioned dose is administered.
14th day after the second dose is administered in accordance with the second column.
(a)365th day (including that day) after the start of the period, unless paragraph (b) applies;
(b)120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS‑CoV‑2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(4)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(5)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1), (2), (3) and (4).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(6)One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
2.Moderna COVID‑19 vaccine
(1)Two doses, administered at least 24 days apart.
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 17 days after the firstmentioned dose is administered.
14th day after the second dose is administered in accordance with the second column.
(a)365th day (including that day) after the start of the period, unless paragraph (b) applies;
(b)120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(4)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(5)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1), (2), (3) and (4).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(6)One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
3.Covishield COVID‑19 vaccine or Vaxzevria
(AstraZeneca COVID‑19 vaccine)
(1)Two doses, administered at least 24 days apart.
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 17 days after the firstmentioned dose is administered.
14th day after the second dose is administered in accordance with the second column.
(a)365th day (including that day) after the start of the period, unless paragraph (b) applies;
(b)120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(4)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(5)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1), (2), (3) and (4).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(6)One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
4.Johnson & Johnson’s
(J&J) Janssen COVID‑19 vaccine
(1)One dose.
14th day after the dose is administered.
365th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(4)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (2) and (3).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
5.Sinopharm COVID‑19 vaccine
(1)Two doses, administered at least 17 days apart.
14th day after the second dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 17 days after the firstmentioned dose is administered.
14th day after the second dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(4)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(5)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1), (2), (3) and (4).
14th day after the last dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(6)Three doses of the defined approved vaccine opposite, administered at least 17 days apart for the first 2 doses and at least 86 days apart between the second and third doses.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(7)Two doses of the defined approved vaccine opposite administered at least 17 days apart, followed by a third dose either of Sinovac-Coronavac COVID‑19 vaccine or another approved vaccine that is not a defined approved vaccine, where the second and third doses are administered at least 86 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(8)One dose of the defined approved vaccine opposite, followed by a dose of another approved vaccine that is not a defined approved vaccine, followed by a dose of a defined approved vaccine, where each dose is administered at least 17 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(9)One dose of the defined approved vaccine opposite, followed by a dose of Sinovac-Coronavac COVID‑19 vaccine where each dose is administered at least 17 days apart, followed by a third dose of any approved vaccine, where the second and third doses are administered at least 86 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(10)Two doses of the defined approved vaccine opposite administered, at least 17 days apart to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(11)Two doses of the defined approved vaccine opposite administered at least 17 days apart, to a recovered individual after recovery from the COVID-19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(12)One dose of the defined approved vaccine opposite, followed by a dose of Sinovac‑Coronavac COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID-19 infection, if he or she is a recovered individual mentioned in paragraph (10).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(13)One dose of the defined approved vaccine opposite, followed by a dose of Sinovac‑Coronavac COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID-19 infection, if he or she is a recovered individual mentioned in paragraph (11).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(14)At least 3 doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (6) to (13).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
6.Sinovac‑Coronavac COVID‑19 vaccine
(1)Two doses, administered at least 13 days apart.
14th day after the second dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 17 days after the firstmentioned dose is administered.
14th day after the second dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(4)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(5)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1), (2), (3) and (4).
14th day after the last dose is administered in accordance with the second column.
120th day (including that day) after the start of the period.
 
(6)Three doses of the defined approved vaccine opposite, administered at least 13 days apart for the first 2 doses and at least 86 days apart between the second and third doses.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(7)Two doses of the defined approved vaccine opposite administered at least 13 days apart, followed by a third dose either of Sinopharm COVID‑19 vaccine or another approved vaccine that is not a defined approved vaccine, where the second and third doses are administered at least 86 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(8)One dose of the defined approved vaccine opposite, followed by a dose of another approved vaccine that is not a defined approved vaccine, followed by a dose of a defined approved vaccine, where each dose is administered at least 17 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(9)One dose of the defined approved vaccine opposite, followed by a dose of Sinopharm COVID‑19 vaccine, where each dose is administered at least 17 days apart, followed by a third dose of any approved vaccine, where the second and third doses are administered at least 86 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(10)Two doses of the defined approved vaccine opposite administered, at least 13 days apart to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(11)Two doses of the defined approved vaccine opposite administered at least 13 days apart to a recovered individual after recovery from the COVID-19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(12)One dose of the defined approved vaccine opposite, followed by a dose of Sinopharm COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID-19 infection, if he or she is a recovered individual mentioned in paragraph (10).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(13)One dose of the defined approved vaccine opposite, followed by a dose of Sinopharm COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID-19 infection, if he or she is a recovered individual mentioned in paragraph (11).
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(14)At least 3 doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (6) to (13).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
7.Covaxin COVID‑19 vaccine
(1)Two doses, administered at least 24 days apart.
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 24 days after the firstmentioned dose is administered.
14th day after the second dose is administered in accordance with the second column.
(a)365th day (including that day) after the start of the period, unless paragraph (b) applies;
(b)120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS‑CoV‑2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(4)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(5)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1), (2), (3) and (4).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(6)One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
8.COVOVAX COVID-19 vaccine or Nuvaxovid (Novavax COVID-19 vaccine)
(1)Two doses, administered at least 17 days apart.
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(2)One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 17 days after the firstmentioned dose is administered.
14th day after the second dose is administered in accordance with the second column.
(a)365th day (including that day) after the start of the period, unless paragraph (b) applies;
(b)120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.
 
(3)One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS-CoV-2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(4)One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID-19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1).
14th day after the dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(5)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1) to (4).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(6)One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart.
Upon the third dose being administered in accordance with the second column.
365th day (including that day) after the start of the period.
[S 991/2021 wef 01/01/2022]
[S 863/2021 wef 10/11/2021]
[S 682/2021 wef 08/09/2021]